Chloe Pass

Safety profile of autologous macrophage therapy for liver cirrhosis

Francesca Moroni, Benjamin J. Dwyer, Catriona Graham et al. · Nature Medicine · 2019 · 201 citations · Full text

Medicine, Immunology, Internal Medicine +12

Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study

Joanna Moore, Alison C. MacKinnon, Dvina Wojtacha et al. · Cytotherapy · 2015 · 51 citations · Full text

Medicine, Immunology, Pathology +17

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Paul Brennan, Mark T. Macmillan, Thomas Manship et al. · Nature Medicine · 2025 · 49 citations · Full text

Medicine, Immunology, Hepatology +16

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)

Paul Brennan, Mark T. Macmillan, Thomas Manship et al. · BMJ Open · 2021 · 45 citations · Full text

Medicine, Translational Sciences, Hepatic Pharmacotherapy +16

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis

Alasdair R. Fraser, Chloe Pass, Paul S. Burgoyne et al. · Cytotherapy · 2017 · 43 citations · Full text

Life Sciences, Cell Biology, Immunology +17